Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.19%
1,066.21
-2.03
-0.19%
—1,068.241,067.921,077.071,063.77——
SIXC
Communications
SIXC
Communications
SIXC
+0.75%
611.16
+4.57
+0.75%
—606.59606.59615.68605.82——
SIXE
Energy
SIXE
Energy
SIXE
+1.82%
1,269.93
+22.72
+1.82%
—1,247.211,244.281,272.821,231.77——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.42%
1,720.41
-7.17
-0.42%
—1,727.581,727.121,727.751,708.63——
SIXM
Financials
SIXM
Financials
SIXM
+1.21%
637.13
+7.59
+1.21%
—629.54628.87637.90628.46——
SIXR
Staples
SIXR
Staples
SIXR
+1.48%
866.25
+12.65
+1.48%
—853.60854.40866.55854.06——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.23%
214.64
+2.60
+1.23%
—212.04212.04214.86212.04——
SIXT
Technology
SIXT
Technology
SIXT
-1.09%
3,511.13
-38.63
-1.09%
—3,549.763,571.063,579.253,461.89——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.05%
886.92
+0.43
+0.05%
—886.49888.59891.95878.92——
SIXV
Health care
SIXV
Health care
SIXV
+0.42%
1,470.49
+6.15
+0.42%
—1,464.341,460.441,471.431,455.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.19%
2,349.77
-4.48
-0.19%
—2,354.252,352.682,379.542,334.76——
PSTV:NASDAQ
Plus Therapeutics Inc
$5.84
+11.24%
(+0.59) 1D
$5.85
+0.17% (+0.010)
After hours
Closed: May 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PSTV...
Open
$5.22
High
$6.03
Low
$5.15
Mkt. cap
40.07M
Avg. vol.
414.65K
Volume
60.00
52-wk high
$23.42
52-wk low
$2.90
EPS
-$7.19
Beta
1.40
Shares outstanding
6.86M
No. of employees
28
News stories
From sources across the web
Profile
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
About Plus Therapeutics Inc
CEO-
Employees28
Founded1996
Headquarters-
SectorBiotechnology
Websiteplustherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.39M
1.40M
1.37M
1.03M
Cost of goods sold
1.25M
2.44M
2.94M
-
Cost of revenue
1.25M
2.44M
2.94M
-
Research and development expenses
-
-
-
2.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.68M
3.44M
4.17M
5.28M
Operating expense
1.68M
3.44M
4.17M
8.15M
Total operating expenses
2.93M
5.88M
7.11M
8.15M
Operating income
-1.54M
-4.48M
-5.74M
-7.12M
Other non operating income
6.66M
-
-
-
EBT including unusual items
5.15M
-4.42M
-5.71M
-6.95M
EBT excluding unusual items
5.15M
-4.42M
-5.71M
-6.95M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
5.15M
-4.42M
-5.71M
-6.95M
Net profit margin
370.58%
-316.61%
-417.92%
-675.68%
Earnings per share
-0.16
-1.00
-
-1.05
Interest and investment income
27.00K
59.00K
29.00K
190.00K
Interest expense
-
-
-
-17.00K
Net interest expenses
27.00K
59.00K
29.00K
173.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.46M
-4.40M
-5.60M
-7.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer